Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism

E-ISSN： 1873-5592|16|12|1372-1380

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.12, 2015-10, pp. : 1372-1380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2648-2666

Bentham Science Publishers

Access to resources Recommend Favorite

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1433-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Diabetic

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 86-87

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Diabetic

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 330-334

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Diabetic

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 469-470

Bentham Science Publishers

Access to resources Recommend Favorite